Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Cancer Immunol Immunother. 2017 Jul 7;66(11):1437–1447. doi: 10.1007/s00262-017-2038-3

Table 2.

Clinical Patient Outcomes

Residual Cancer Burden Class N (%)
All Patients 24
RCB 0 10 (42)
RCB I 4 (17)
RCB II 8 (33)
RCB III 2 (8)
Complete Pathologic Response (pCR) 11 (46)
No Complete Pathologic Response 13 (54)